Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Apr 18, 2023
Document Date
Apr 14, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
CHASE WILLIAM J